|
|
|
|
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
V. Ratziu, L. de Guevara, R. Safadi, F. Poordad, F. Fuster, J. Flores-Figueroa, S.A. Harrison, M. Arrese, S. Fargion, D. Ben Bashat, C. Lackner, T. Gorfine, S. Kadosh, R. Oren, R. Loomba and A.J. Sanyalon behalf of the ARREST investigator study group
|
|
|
|
|
|
|